10-K
XBRL
FORM 10-K
- Company
- INTEGRATED BIOPHARMA INC
- Filed
- September 12, 2018
- Period of Report
- June 30, 2018
- Accession Number
- 0001437749-18-016922
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →